Michaelmas Term - Experimental Physiology Background and Debrief Sheets
Term Sheets for Advanced and Financing Rounds€¦ · Term Sheets for Advanced and Financing Rounds...
Transcript of Term Sheets for Advanced and Financing Rounds€¦ · Term Sheets for Advanced and Financing Rounds...
1
1
Term Sheets for Advanced and Financing Rounds Pascal Honold
Bern, 24 October 2012
Bern, 24 October 2012 2
Introduction
The Speaker Handout – Term Sheet Template Raise your voice!
2
Bern, 24 October 2012 3
Agenda 1. The Big Picture 2. Purpose / Importance of a Term Sheet 3. Usual Content of a Term Sheet 4. Value Drivers 5. Questions / Discussion
4
The Big (Development) Picture (I)
Inventor 2 ½%
Trendsetter 13 ½%
Skeptic 34%
Laggard 16%
Early Stage Developed Market
Bern, 24 October 2012
Mass Market
Progressive 34%
3
5
The Big (Turnover) Picture (II)
Turnover
Bern, 24 October 2012
Timeline
Business Angels
FFF: Family, Friends & Fools
VC Series A, B, etc.
Invention Seed Early Stage Growth Mature Market
Cash flow negative Cash flow positive Break Even
Bern, 24 October 2012 6
The Big (Financing) Picture (III) Who finances?
1. Business- / Product Idea
2. „Seed“: from an idea to know-how / IPR / Prototype etc.
3. Incorporation: in cash and/or by contribution in kind
4. Financing Round 1: first bigger outside financing round
5. Financing Round 2: further outside Investors
7. Exit: IPO, Trade Sale, Secondary Sale, Buy Back
6. Financing Round N: further outside Investors
FFF
Business Angels
Venture
Capitalists
4
7
The Big (Transaction) Picture (IV)
Business Plan and Investors Presentation
Preparation of the Due Diligence
Analysis of the opportunities
Definition of Objectives
Selection of consultants
Financial Plan
Valuation Models
Taxes
Preparation of a list of Potential Investors
Preparation of the Information (Executive
Summary, Business plan)
Confidentiality Agreement
Term Sheet / LOI
Due Diligence Customer references
Investment Agreement
Shareholders‘ Agreement
Signing & Closing
Final Negotiations
Negotiation
Further Agreements
3 Months and more 3 Months and more 1- 2 Months
Preparation Negotiation Execution
4 to 8 Months
Bern, 24 October 2012 8
2) Purpose / Importance of a Term Sheet
1. Fixing the key figures and clauses for the investment and shareholders’ agreement
2. Ruling the negotiation procedure (time schedule, exclusivity, costs etc.)
3. Legal: tentative agreement, i.e., agreement to conclude a contract (art. 22 SCO) – not binding unless otherwise agreed.
4. In practice: virtually binding nature; sound justification needed for deviation from term sheet.
5
Bern, 24 October 2012 9
3) Usual Content of a Term Sheet (I)
3.1 Investment Agreement 3.2 Shareholders Agreement
Rules about
- the amount
- the preconditions and
- the protection
of the investment
Rules about the relationship
between the investor(s) and the
other shareholders after the
investment
1. Term Sheet
2. Negotiations / Due Diligence
Bern, 24 October 2012 10
3) Usual Content of a Term Sheet (II)
Parties: Company, Investor(s), Founders,
Existing Shareholders
Invested amount / tranches; funding type
Use of the invested proceeds
Employee Stock Option Plan (ESOP)
Share price and type of shares
Cap table; pre- and post-money valuation
Milestones / Business Plan
Representations and Warranties
Conditions Precedent
Investment Agreement Issues
(Escrow for shares / share certificates)
6
Bern, 24 October 2012 11
3) Usual Content of a Term Sheet (III)
Voting rights / Qualified Majorities
Composition of Board / Management Information Requirements
Conversion of Preferred Shares
Preference Rights (Dividend, Subscription, Liquidation,
General Transfer Restrictions / Right of First Refusal
Funding / Financial Matters Related Party Transactions
Exit provisions (Tag- and Drag-along, IPO, Purchase Options)
Shareholders Agreement Issues
Non-competition / non-solicitation Anti-Dilution Protection
Bern, 24 October 2012 12
3) Usual Content of a Term Sheet (IV)
Timing
Costs / Break-up Fee
Exclusivity
Applicable Law
Jurisdiction / Arbitration Clause
Binding / Non-Binding Effect
Procedural and General Aspects
Confidentiality
7
13
4) Value Drivers
• Pre Money Valuation
• Size of Investment Round
• Size of ESOP
• Allocation of ESOP
• Liquidation Preference
• Anti Dilution Protection
• Representations & Warranties
• Milestones
Bern, 24 October 2012
14
Example: Financing Round Series A
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 30‘000
30‘000 Shares
Pre Money Valuation CHF 10 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 100
Post Money Valuation CHF 13 Mio.
Value per share: CHF 100
• Pre Money Valuation (fully diluted) CHF 10 Mio. • Number of existing shares: 100‘000 • Number of newly issued shares: 30‘000 • New share capital including agio: CHF 3 Mio. • Value per share pre and post transaction remains the same: CHF 100
Bern, 24 October 2012
8
15
Pre Money Valuation
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 30‘000
30‘000 Shares
Pre Money Valuation CHF 10 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 100
Post Money Valuation CHF 13 Mio.
Value per share: CHF 100
Bern, 24 October 2012
Pre Money # Shares Value per Share Investment # Shares Total ShareholdingsSeries A Series A Pre Post Dilution
10'000'000 100'000 100 3'000'000 30'000 130'000 100.00% 76.92% 23.08%4'000'000 100'000 40 3'000'000 75'000 175'000 100.00% 57.14% 42.86%6'000'000 100'000 60 3'000'000 50'000 150'000 100.00% 66.67% 33.33%8'000'000 100'000 80 3'000'000 37'500 137'500 100.00% 72.73% 27.27%12'000'000 100'000 120 3'000'000 25'000 125'000 100.00% 80.00% 20.00%20'000'000 100'000 200 3'000'000 15'000 115'000 100.00% 86.96% 13.04%
Rule of Thumb: The lower the PM valuation,
the greater the dilution.
16
Size of Investment Round
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 30‘000
30‘000 Shares
Pre Money Valuation CHF 10 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 100
Post Money Valuation CHF 13 Mio.
Value per share: CHF 100
Bern, 24 October 2012
Pre Money # Shares Value per Share Investment # Shares Total ShareholdingsSeries A Series A Pre Post Dilution
10'000'000 100'000 100 1'000'000 10'000 110'000 100.00% 90.91% 9.09%10'000'000 100'000 100 2'000'000 20'000 120'000 100.00% 83.33% 16.67%10'000'000 100'000 100 3'000'000 30'000 130'000 100.00% 76.92% 23.08%10'000'000 100'000 100 4'000'000 40'000 140'000 100.00% 71.43% 28.57%10'000'000 100'000 100 5'000'000 50'000 150'000 100.00% 66.67% 33.33%10'000'000 100'000 100 6'000'000 60'000 160'000 100.00% 62.50% 37.50%
Rule of Thumb: The greater the size of IR, the greater the dilution.
9
17
Size of ESOP
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 30‘000
30‘000 Shares
Pre Money Valuation CHF 10 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 100
Post Money Valuation CHF 13 Mio.
Value per share: CHF 100
Bern, 24 October 2012
ESOP
Pre Money # Shares Value per Share Investment # Shares Total Size ESOPSeries A Series A Post # Shares ESOP # Shares Dilution
Total10'000'000 100'000 100 3'000'000 30'000 130'000 6% 8'298 138298 27.69%10'000'000 100'000 100 3'000'000 30'000 130'000 8% 11'304 141304 29.23%10'000'000 100'000 100 3'000'000 30'000 130'000 10% 14'444 144444 30.77%10'000'000 100'000 100 3'000'000 30'000 130'000 12% 17'727 147727 32.31%10'000'000 100'000 100 3'000'000 30'000 130'000 14% 21'163 151163 33.85%10'000'000 100'000 100 3'000'000 30'000 130'000 16% 24'762 154762 35.38%
Rule of Thumb: The greater the size of ESOP, the greater the
dilution.
18
Allocation of ESOP
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 30‘000
30‘000 Shares
Pre Money Valuation CHF 10 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 100
Post Money Valuation CHF 13 Mio.
Value per share: CHF 100
Bern, 24 October 2012
ESOP
ESOP
ESOP
???
Founder pays the ESOP
Investors pay the ESOP Pro rata
10
19
Liquidation Preference (1)
Bern, 24 October 2012
• Investor receives before common shareholder his investment as liquidation proceed or dividend
• Pre Money Valuation (fully diluted) CHF 10 Mio. • Number of existing shares: 150‘000
• Founders/Common shareholders: 100‘000 (i.e., 66.66%) • ESOP 20‘000 (i.e., 13.34%) • Investor Series A: 30‘000 (i.e., 20%); Investment amount CHF 3 Mio.
• Exit after 3 years • Exit value: CHF 20 Mio.
• Structure of Liquidation Preferences • 1x liquidation preference • 1x liquidation preference with catch up for common shareholders • 1x liquidation preference with 10 %coupon • 2x liquidation preference with 10% coupon
20
Liquidation Preference (2)
Bern, 24 October 2012
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
18.0
20.0
Investment 1x Liquidationpreference
1x Liquidationpreference with
catch up forcommon
shareholders
1x Liquidationpreference with
10 percentcoupon
2x Liquidationpreference with
10 percentcoupon
ESOPCatch upCommon ShareholdersInvestor ACouponLiquidation preference
11
21
Liquidation Preference (3) - Analysis
Bern, 24 October 2012
A Round: Investors A 3 m Sh: 20% Common 10 m Sh: 66.66% ESOP 2 m Sh: 13.34%
1 x Liq. Pref: Investors 6.4 m Return 113% Common 11.3 m Return 13% (since Round series A) ESOP 2 m
1 x Liq. Pref w/ catch up: Investors 4.4 m Return 46% Common 14.7 m Return 47% (since Round series A) ESOP 0.9 m
1 x Liq. Pref w/ 10%c: Investors 7.1 m Return 136% Common 10.7 m Return 7% (since Round series A) ESOP 2.1 m
2 x Liq. Pref w/ 10%c: Investors 10.2 m Return 240% Common 8.1 m Return -19% (since Round series A) ESOP 1.6 m
22
Anti Dilution Protection
Bern, 24 October 2012
• Protection of Investor A in case of a future down round • Full ratchet/weighted average
• Down round: • Pre Money Valuation Series B (fully diluted) CHF 5 Mio. • Number of existing shares:
• 100‘000 Common • 30‘000 Series A • ESOP 20‘000
• New share capital including agio: CHF 3 Mio.
12
23
Anti Dilution Adjustment – Full Ratchet
Common 100'000 33.33%ESOP 20'000 6.67%Series A 90'000 30.00%Series B 90'000 30.00%
300'000 100.00%
Bern, 24 October 2012
Remarks:
Value per share new: CHF 33.33
Investor receives 60‘000 shares
(Series A Investment of CHF 3 Mio. divided by the new share price of CHF 33.3 gives 90‘000 of which 30‘000 were already received)
Technically shares are either issued or transferred to Investor A
Pre Money # Shares # Shares # Shares Total Value p share # New shares Anti DilutionCommon Series A ESOP Adjustment
10'000'000 100'000 30'000 20'000 150'000 33.33 90'000 60'000
Significant dilution Of common shareholders
24
Anti Dilution Adjustment – Weighted Average
Common 100'000 39.22%ESOP 20'000 7.84%Series A 45'000 17.65%Series B 90'000 35.29%
255'000 100.00%
Bern, 24 October 2012
Remarks:
Value per share new: CHF 33.33
Weighted value per share:
(CHF 100 + CHF 33.33 ) /2 = 66.66
Investor receives 15‘000 shares
(Series A Investment of CHF 3 Mio. divided by the new share price of CHF 66.66 gives 45‘000 of which 30‘000 were already received)
Pre Money # Shares # Shares # Shares Total Value p share # New shares Anti DilutionCommon Series A ESOP Adjustment
10'000'000 100'000 30'000 20'000 150'000 33.33 90'000 15'000
13
25
Representations & Warranties Milestones
Bern, 24 October 2012
• Company fails to meet milestones • Company violates representations and warranties
• Reduction of the valuation of the company and the value per share • Shares will be either transferred or newly issued
26
Representations & Warranties Milestones
Pre capital increase Share capital CHF 100‘000
100‘000 Shares
Post capital increase Share capital CHF 130‘000
130‘000 Shares
Capital increase Share Capital CHF 33‘333
30‘000 Shares
New Pre Money Valuation CHF 9 Mio.
Value per share: CHF 100
CHF 3 Mio. Value per share: CHF 90
Post Money Valuation CHF 12 Mio.
Value per share: CHF 90
Bern, 24 October 2012
Reduction of the valuation on a $ by $
basis
Post Money Valuation CHF 12 Mio.
Value per share: CHF 100
Pre Money # Shares Value per Share Investment # Shares TotalSeries A Series A Dilution
10'000'000 100'000 100 3'000'000 30'000 130'000 23.08%Damage of CHF 1 Mio. 9'000'000 100'000 90 3'000'000 33'333 133'333 25.00%
14
Bern, 24 October 2012 27
Any Questions?
28
Thanks.
Pascal Honold Wenger & Vieli Ltd. Dufourstrasse 56 8034 Zurich Phone: 058 / 958 58 58 E-mail: [email protected]
Bern, 24 October 2012